Conavi Medical Reports Fiscal Third Quarter 2026 Results and Operational Highlights
Net loss for Fiscal Q3 2026 was $6.3 million (Fiscal Q3 2025 – $3.6 million) reflecting continued investment in research and development activities of $4.4 million (Fiscal Q3 2025 – $3.2 million) Ended Fiscal Q3 2026 with $0.9M in cash and cash equivalents (Fiscal Q4 2025 – $5.8 million) and on August 12, 2026 closed […]
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
